Entheon Biomedical Corp ENTBF:OTCPK

RT Quote | Exchange | USD
Last | 02/26/21 EST
0.65quote price arrow up+0.02 (+3.17%)
Volume
104,064
52 week range
0.38 - 2.00

...

Loading . . .

KEY STATS

  • Open0.60
  • Day High0.65
  • Day Low0.5889
  • Prev Close0.63
  • 52 Week High2.00
  • 52 Week High Date01/22/21
  • 52 Week Low0.38
  • 52 Week Low Date11/25/20
  • Market Cap3.77M
  • Shares Out6.04M
  • 10 Day Average Volume219,952.09
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.06
  • P/E (TTM)-10.05
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Entheon Biomedical Corp News

There is no recent news for this security.

Latest ENTBF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Entheon Biomedical Corp., formerly MPV Exploration Inc., is a biotechnology research and development company. The Company focuses on developing a portfolio of Dimethyltryptamine (DMT) based psychedelic therapeutic products for treating addiction and substance use disorders. It focuses on providing therapeutics for severe depression, severe Post-traumatic stress disorder (PTSD) and treatment resistant depression.
Address
211-3030 Lincoln Avenue
Coquitlam, BC
V3B 6B4
Canada